Short Communication

British Journal of Cancer (2003) 88, 672–674. doi:10.1038/sj.bjc.6600820 www.bjcancer.com
Published online 4 March 2003

Aspirin use and cancers of the upper aerodigestive tract

C Bosetti1, R Talamini2, S Franceschi3, E Negri1, W Garavello4 and C La Vecchia1,5

  1. 1Istituto di Ricerche Farmacologiche 'Mario Negri', Via Eritrea 62, 20157 Milan, Italy
  2. 2Servizio di Epidemiologia, Centro di Riferimento Oncologico, Via Pedemontana Occ.le, 33081 Aviano (Pordenone), Italy
  3. 3International Agency for Research on Cancer, 150 Cours Albert Thomas, F-69372 Lyon Cédex 08, France
  4. 4Ospedale 'San Gerardo', Università di Milano Bicocca, Via Donizetti 106, 20052 Monza, Italy
  5. 5Istituto di Statistica Medica e Biometria, Università degli Studi di Milano, Via Venezian 1, 20133 Milan, Italy

Correspondence: Dr C Bosetti, E-mail: bosetti@marionegri.it

Received 14 October 2002; Revised 15 December 2002; Accepted 18 December 2002.

Top

Abstract

The role of aspirin on the risk of cancers of the upper aerodigestive tract was investigated in the combined data of three Italian case–control studies, including 965 cases and 1779 hospital controls. The odds ratio was 0.33 for users of greater than or equal to5 years, and 0.51 for greater than or equal to5 years since first use.

Keywords:

upper aerodigestive tract cancer, aspirin, case–control study, risk factor